2'-溴-5'-氟苯乙酮 | 1006-33-3

• 物质功能分类: 有机原料 - 酮类化合物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2'-溴-5'-氟苯乙酮
• 中文别名: 2’-溴-5’-氟苯乙酮；2-溴-5-氟苯乙酮
• 英文名称: 1-(2-bromo-5-fluorophenyl)ethan-1-one
• 英文别名: 1-(2-bromo-5-fluorophenyl)ethanone；2'-bromo-5'-fluoroacetophenone
• CAS: 1006-33-3
• 化学式: C₈H₆BrFO
• 分子量: 217.037
• InChiKey: BQXROZQUDCJBBY-UHFFFAOYSA-N

物化性质

• 沸点：
  144℃/18mm
• 密度：
  1.535±0.06 g/cm3(Predicted)
• 溶解度：
  溶于甲醇。

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2914700090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  存于室温下，密封保存，并确保环境干燥。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
2’-Bromo-5’-fluoroacetophenone
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
2’-Bromo-5’-fluoroacetophenone
Ingredient name:
CAS number: 1006-33-3

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H6BrFO
Molecular weight: 217

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2'-溴-5'-氟苯乙酮 在 盐酸羟胺 、 sodium acetate 作用下， 以 乙醇 、 水 为溶剂， 生成 (E)-1-(2-bromo-5-fluorophenyl)ethan-1-one oxime
  参考文献：
  名称：

  室温下空气中铜的胺的N-芳基化反应具有百万分之几的催化剂负载量。

  摘要：

  已经开发出一种有效的铜催化的胺N-芳基化方法，室温下在空气中的百万分之几的催化剂负载量。取代的（E）-1-（2-卤代苯基）烷酮肟与脂族胺或芳族胺的反应提供了良好收率的N-芳基化产物。

  DOI：

  10.1039/c1cc13516c
• 作为产物：
  描述：

  methyl 3-(2-bromo-5-fluorophenyl)-3-oxopropionate 在 盐酸 作用下， 生成 2'-溴-5'-氟苯乙酮
  参考文献：
  名称：

  [EN] PROCESS FOR THE PRODUCTION OF FUSED, TRICYCLIC SULFONAMIDES
  [FR] PROCÉDÉ DE PRODUCTION DE SULFONAMIDES TRICYCLIQUES FUSIONNÉS

  摘要：

  公开号：

  WO2010111418A3

文献信息

• Allylic Arylation of 1,3-Dienes via Hydroboration/Migrative Suzuki–Miyaura Cross-Coupling Reactions
  作者：Xiao-Ming Zhang、Jie Yang、Qing-Bo Zhuang、Yong-Qiang Tu、Zongyuan Chen、Hui Shao、Shao-Hua Wang、Fu-Min Zhang

  DOI：10.1021/acscatal.8b01823

  日期：2018.7.6

  The hydroboration/Pd-catalyzed migrative Suzuki–Miyaura cross-coupling of 1,3-dienes with electron-deficient aryl halides has been developed, which enables the synthesis of branched allylarenes directly from primary homoallylic alkyl boranes. A ligand-tuned linear- or branch-selective coupling for these aryl halides has also been achieved.

  1,3-二烯与缺电子的芳基卤化物的加氢硼化/ Pd催化迁移性Suzuki-Miyaura交叉偶联已经发展，这使得直接从伯均烯丙基烷基硼烷直接合成支链烯丙基芳烃成为可能。对于这些芳基卤化物，也已经实现了配体调谐的线性或分支选择性偶联。
• Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines
  申请人：Ridgway Hugh Brian

  公开号：US20060025436A1

  公开（公告）日：2006-02-02

  Synthetic methods are provided for production of compounds of the formula: where R 1 , R 2 , R 3 , R4, R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 and R 14 are as defined in the specification.

  提供了一种用于生产以下公式化合物的合成方法：其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12、R13和R14如说明书中所定义。
• Scalable Approach to Fluorinated Heterocycles with Sulfur Tetrafluoride (SF₄)
  作者：Serhii Trofymchuk、Maksym Bugera、Anton A. Klipkov、Volodymyr Ahunovych、Bohdan Razhyk、Sergey Semenov、Andrii Boretskyi、Karen Tarasenko、Pavel K. Mykhailiuk

  DOI：10.1021/acs.joc.1c01518

  日期：2021.9.3

  A general approach to fluorinated (hetero)aromatic derivatives is elaborated. The key reaction is a deoxofluorination of substituted acetophenones with sulfur tetrafluoride (SF4). In contrast to previous deoxofluorination methods, this transformation is fast, scalable (up to 70 g), and high-yielding. More than 100 novel or previously hardly accessible fluorinated heterocycles, interesting for medicinal

  详细阐述了氟化（杂）芳族衍生物的一般方法。关键反应是取代苯乙酮与四氟化硫 (SF 4 )的脱氧氟化。与之前的脱氧氟化方法相比，这种转化速度快、可扩展（高达 70 g）且产量高。合成了 100 多种新颖的或以前难以获得的氟化杂环，对药物化学和农业化学很感兴趣。
• [EN] FACTOR XIa INHIBITORS<br/>[FR] INHIBITEURS DU FACTEUR XIA
  申请人：MERCK SHARP & DOHME

  公开号：WO2017074832A1

  公开（公告）日：2017-05-04

  The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma Kallikrein.

  本发明提供了一种化合物（I）的化合物，以及包含一种或多种所述化合物的药物组合物，并且提供了使用所述化合物用于治疗或预防血栓形成、栓塞、高凝血性或纤维变化的方法。这些化合物是选择性因子XIa抑制剂或因子XIa和血浆激肽酶的双重抑制剂。
• [EN] IRE1 SMALL MOLECULE INHIBITORS<br/>[FR] PETITES MOLÉCULES INHIBITRICES D'IRE1
  申请人：QUENTIS THERAPEUTICS INC

  公开号：WO2018222918A1

  公开（公告）日：2018-12-06

  Provided herein are small molecule inhibitors for the targeting or IRE1 protein family members. Binding may be direct or indirect. Further provided herein are methods of using IRE1 small molecule inhibitors for use in treating or ameliorating cancer in a subject. Moreover, IRE1 small molecule inhibitors described herein are for the treatment of cancer, where the cancer is a solid or hematologic cancer.

  本文提供了针对IRE1蛋白家族成员的小分子抑制剂。结合可以是直接的或间接的。此外，本文提供了使用IRE1小分子抑制剂用于治疗或改善受试者癌症的方法。此外，本文描述的IRE1小分子抑制剂用于治疗癌症，其中癌症是实体或血液系统的癌症。